This biotech stock rallying on cancer treatment data has more room to run, analysts say

Analysts are closely watching Merus and see more upside ahead coming out of one of the…

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes…

Palantir, Applovin fuel a can’t lose market. That’s dangerous for all stocks

You can’t ban froth. You can’t ban lunacy, especially when it pays off. You can’t tell…

S&P 500 tumbles for a second day, dragged lower by Microsoft and Meta: Live updates

Specialist traders work inside a post on the floor at the New York Stock Exchange (NYSE)…

Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon

Sebastien Bozon | AFP | Getty Images With massive corporations including Alphabet, Meta, Apple, Microsoft and…

Eli Lilly’s blowout quarter should quiet investor concerns about the stock

Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and…